Sterling Bio Machines
Novel bioreactors that will unlock the power of synthetic biology and transform global manufacturing.
- Cohort
- Autumn 24
- Sector
- Healthcare & Life Sciences · Industrial & Manufacturing
What they do
Sterling has invented a new class of modular bioreactors that separate cell culture from media conditioning. They will achieve cell densities exceeding 100M cells/ml, enable scaling from laboratory to commercial production 6X faster, and cost 50% less to own and operate.
Product & technology
Developed a novel bioreactor system addressing shortcomings of traditional technologies.
Demo
Why we invested
- →Addressing a bottleneck in the industry from an outside perspective
- →Large market opportunity if they can appropriately scale their bioreactor
- →Strong Team, with CEO having prior start up experience
Technology
Biotech & DiagnosticsSynthetic BiologyAdvanced Manufacturing
Impact
Next Generation Living
